A Randomized Controlled Study of Efficacy and Safety of Accelerated Versus Standard Hepatitis B Vaccination in Patients With Advanced CKD

A Randomized Controlled Study of Efficacy and Safety of Accelerated Versus Standard Hepatitis B Vaccination in Patients With Advanced CKD

Introduction: Hepatitis B virus (HBV) vaccination is crucial for seronegative patients with advanced chronic kidney disease (CKD) for protection during dialysis while preparing for transplantation. A standard regimen for HBV vaccination requires 24 weeks to be completed. An accelerated HBV vaccinati...

Full description

Saved in:
Bibliographic Details
Main Authors: Jathurong Kittrakulrat, Kanitha Tiankanon, Stephen J. Kerr, Salin Wattanatorn, Suwasin Udomkarnjananun, Somkanya Tungsanga, Roongruedee Chaiteerakij, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Yingyos Avihingsanon, Khajohn Tiranathanagul, Jakapat Vanichanan, Natavudh Townamchai
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Kidney International Reports
Subjects:
anti-HBs
chronic kidney disease
hepatitis B
hepatitis B vaccination
kidney transplantation
seroconversion
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924000159
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468024924000159

Similar Items